Literature DB >> 16679355

Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.

J P A Baak1, A-J Kruse, S J Robboy, E A M Janssen, B van Diermen, I Skaland.   

Abstract

The microscopic phenotype of cervical intraepithelial neoplasia (CIN) reflects a fine balance between factors that promote or reduce CIN development. A shortcoming of the current grading system is its reliance on static morphology and microscopic haematoxylin-eosin features of the epithelium alone. In reality, CIN is a dynamic process, and the epithelium may exhibit differing results over time. Functional biomarkers p16, Ki-67, p53, retinoblastoma protein cytokeratin (CK)14 and CK13, help in the assessment of an individual CIN's lesion's potential for progression and regression. The aggregate information provided by these biomarkers exceeds the value of the classic grading system. Consequently, many more CINs that will either regress or progress can be accurately identified. These findings agree with known molecular interactions between HPV and the host. For accurate interpretation of a CIN, it is essential that these biomarkers be determined quantitatively and separately in the superficial, middle and deep layers of the epithelium. Such geography-specific epithelial evaluations of quantitative biomarkers emphasise the dynamic nature of a particular CIN lesion, thereby changing the art of static morphology grading into dynamic interpretation of the diseased tissue, with a strong prognostic effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16679355      PMCID: PMC1861745          DOI: 10.1136/jcp.2005.027839

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  96 in total

1.  Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix.

Authors:  S A Southern; I W McDicken; C S Herrington
Journal:  Hum Pathol       Date:  2001-12       Impact factor: 3.466

2.  Relationship between the presence of oncogenic HPV DNA assessed by polymerase chain reaction and Ki-67 immunoquantitative features in cervical intraepithelial neoplasia.

Authors:  A J Kruse; J P Baak; P C de Bruin; F R van de Goot; N Kurten
Journal:  J Pathol       Date:  2001-12       Impact factor: 7.996

3.  Diagnostic Accuracy of Cervical Low-Grade Squamous Intraepithelial Lesions Is Improved With MIB-1 Immunostaining.

Authors:  Edyta C Pirog; Rebecca N Baergen; Robert A Soslow; Diane Tam; Amy E DeMattia; Yao-Tseng Chen; Christina Isacson
Journal:  Am J Surg Pathol       Date:  2002-01       Impact factor: 6.394

4.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

Authors:  C B Woodman; S Collins; H Winter; A Bailey; J Ellis; P Prior; M Yates; T P Rollason; L S Young
Journal:  Lancet       Date:  2001-06-09       Impact factor: 79.321

5.  Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri.

Authors:  R Klaes; T Friedrich; D Spitkovsky; R Ridder; W Rudy; U Petry; G Dallenbach-Hellweg; D Schmidt; M von Knebel Doeberitz
Journal:  Int J Cancer       Date:  2001-04-15       Impact factor: 7.396

6.  Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

Authors:  Mark E Sherman; Mark Schiffman; J Thomas Cox
Journal:  J Natl Cancer Inst       Date:  2002-01-16       Impact factor: 13.506

7.  Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.

Authors:  J T Keating; A Cviko; S Riethdorf; L Riethdorf; B J Quade; D Sun; S Duensing; E E Sheets; K Munger; C P Crum
Journal:  Am J Surg Pathol       Date:  2001-07       Impact factor: 6.394

8.  A randomized clinical trial of 4-hydroxyphenylretinamide for high-grade squamous intraepithelial lesions of the cervix.

Authors:  M Follen; E N Atkinson; D Schottenfeld; A Malpica; L West; S Lippman; C Zou; W N Hittelman; R Lotan; W K Hong
Journal:  Clin Cancer Res       Date:  2001-11       Impact factor: 12.531

9.  A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia.

Authors:  K A Keefe; M J Schell; C Brewer; M McHale; W Brewster; J A Chapman; G S Rose; D S McMeeken; W Lagerberg; Y M Peng; S P Wilczynski; H Anton-Culver; F L Meyskens; M L Berman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-10       Impact factor: 4.254

10.  The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix.

Authors:  C A Sun; H C Lai; C C Chang; S Neih; C P Yu; T Y Chu
Journal:  Gynecol Oncol       Date:  2001-10       Impact factor: 5.482

View more
  29 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

2.  On-chip immunofluorescence analysis of single cervical cells using an electroactive microwell array with barrier for cervical screening.

Authors:  Makoto Takeuchi; Kazunori Nagasaka; Mina Yoshida; Yoshiko Kawata; Yuko Miyagawa; Saori Tago; Haruko Hiraike; Osamu Wada-Hiraike; Katsutoshi Oda; Yutaka Osuga; Tomoyuki Fujii; Takuya Ayabe; Soo Hyeon Kim; Teruo Fujii
Journal:  Biomicrofluidics       Date:  2019-07-30       Impact factor: 2.800

3.  Toward development of a large field-of-view cancer screening patch (CASP) to detect cervical intraepithelial neoplasia.

Authors:  John Gawedzinski; Kathleen M Schmeler; Andrea Milbourne; Preetha Ramalingam; Parnian A Moghaddam; Rebecca Richards-Kortum; Tomasz S Tkaczyk
Journal:  Biomed Opt Express       Date:  2019-11-06       Impact factor: 3.732

4.  Prediction of clinical outcome using p16INK4a immunocytochemical expression in low-grade squamous intraepithelial lesions and high-risk HPV-positive atypical squamous cells of undetermined significance in patients with and without colposcopic evident cervical disease.

Authors:  Ankica Lukic; Giorgio Sbenaglia; Elisabetta Carico; Matilde DI Properzio; Enrico Giarnieri; Antonio Frega; Flavia Nobili; Massimo Moscarini; Maria Rosaria Giovagnoli
Journal:  Exp Ther Med       Date:  2011-07-01       Impact factor: 2.447

5.  [Diagnosis and grading of cervical intraepithelial neoplasias].

Authors:  C Rosamilia; G Feichter; A Tzankov; E C Obermann
Journal:  Pathologe       Date:  2012-03       Impact factor: 1.011

6.  Does CIN2 Have the Same Aggressive Potential As CIN3? A Secondary Analysis of High-Grade Cytology Recurrence in Women Treated with Cold-Coagulation Cervical Treatment.

Authors:  D Papoutsis; M Underwood; W Parry-Smith; J Panikkar
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-03       Impact factor: 2.915

7.  Characterization of Molecular Markers Indicative of Cervical Cancer Progression.

Authors:  Hilal Arnouk; Mark A Merkley; Robert H Podolsky; Hubert Stöppler; Carlos Santos; Manuel Alvarez; Julio Mariategui; Daron Ferris; Jeffrey R Lee; William S Dynan
Journal:  Proteomics Clin Appl       Date:  2009-05-05       Impact factor: 3.494

Review 8.  Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Authors:  Kate Cuschieri; Nicolas Wentzensen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

9.  Double staining cytologic samples with quantitative Feulgen-thionin and anti-Ki-67 immunocytochemistry as a method of distinguishing cells with abnormal DNA content from normal cycling cells.

Authors:  Gerald Li; Martial Guillaud; Michele Follen; Calum MacAulay
Journal:  Anal Quant Cytopathol Histpathol       Date:  2012-10

10.  The impact of Aurora kinase A genetic polymorphisms on cervical cancer progression and clinicopathologic characteristics.

Authors:  Pei-Ju Wu; Chun-Hao Wang; Ming-Hong Hsieh; Chung-Yuan Lee; Po-Hui Wang; Chiao-Wen Lin; Shun-Fa Yang; Maw-Sheng Lee
Journal:  Int J Med Sci       Date:  2021-04-22       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.